897 related articles for article (PubMed ID: 21228259)
61. What ligand-gated ion channels can tell us about the allosteric regulation of G protein-coupled receptors.
Ehlert FJ
Prog Mol Biol Transl Sci; 2013; 115():291-347. PubMed ID: 23415097
[TBL] [Abstract][Full Text] [Related]
62. The role of conformational ensembles in ligand recognition in G-protein coupled receptors.
Niesen MJ; Bhattacharya S; Vaidehi N
J Am Chem Soc; 2011 Aug; 133(33):13197-204. PubMed ID: 21766860
[TBL] [Abstract][Full Text] [Related]
63. Extracellular calcium modulates actions of orthosteric and allosteric ligands on metabotropic glutamate receptor 1α.
Jiang JY; Nagaraju M; Meyer RC; Zhang L; Hamelberg D; Hall RA; Brown EM; Conn PJ; Yang JJ
J Biol Chem; 2014 Jan; 289(3):1649-61. PubMed ID: 24280223
[TBL] [Abstract][Full Text] [Related]
64. Endogenous allosteric modulators of G protein-coupled receptors.
van der Westhuizen ET; Valant C; Sexton PM; Christopoulos A
J Pharmacol Exp Ther; 2015 May; 353(2):246-60. PubMed ID: 25650376
[TBL] [Abstract][Full Text] [Related]
65. Identification of monellin as the first naturally derived proteinaceous allosteric agonist of metabotropic glutamate receptor 5.
Chen ANY; Hellyer SD; Trinh PNH; Leach K; Gregory KJ
Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6():104-115. PubMed ID: 30983151
[TBL] [Abstract][Full Text] [Related]
66. Allosteric Modulators of the Class A G Protein Coupled Receptors.
Tschammer N
Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
[TBL] [Abstract][Full Text] [Related]
67. Investigating the molecular mechanism of positive and negative allosteric modulators in the calcium-sensing receptor dimer.
Jacobsen SE; Gether U; Bräuner-Osborne H
Sci Rep; 2017 Apr; 7():46355. PubMed ID: 28417952
[TBL] [Abstract][Full Text] [Related]
68. Bridging the gap: bitopic ligands of G-protein-coupled receptors.
Lane JR; Sexton PM; Christopoulos A
Trends Pharmacol Sci; 2013 Jan; 34(1):59-66. PubMed ID: 23177916
[TBL] [Abstract][Full Text] [Related]
69. Determining allosteric modulator mechanism of action: integration of radioligand binding and functional assay data.
Langmead CJ
Methods Mol Biol; 2011; 746():195-209. PubMed ID: 21607858
[TBL] [Abstract][Full Text] [Related]
70. Two distinct determinants of ligand specificity in T1R1/T1R3 (the umami taste receptor).
Toda Y; Nakagita T; Hayakawa T; Okada S; Narukawa M; Imai H; Ishimaru Y; Misaka T
J Biol Chem; 2013 Dec; 288(52):36863-77. PubMed ID: 24214976
[TBL] [Abstract][Full Text] [Related]
71. The sweet taste of true synergy: positive allosteric modulation of the human sweet taste receptor.
Servant G; Tachdjian C; Li X; Karanewsky DS
Trends Pharmacol Sci; 2011 Nov; 32(11):631-6. PubMed ID: 21807420
[TBL] [Abstract][Full Text] [Related]
72. PAM-Antagonists: A Better Way to Block Pathological Receptor Signaling?
Kenakin T; Strachan RT
Trends Pharmacol Sci; 2018 Aug; 39(8):748-765. PubMed ID: 29885909
[TBL] [Abstract][Full Text] [Related]
73. International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.
Leach K; Hannan FM; Josephs TM; Keller AN; Møller TC; Ward DT; Kallay E; Mason RS; Thakker RV; Riccardi D; Conigrave AD; Bräuner-Osborne H
Pharmacol Rev; 2020 Jul; 72(3):558-604. PubMed ID: 32467152
[TBL] [Abstract][Full Text] [Related]
74. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs.
Congreve M; Oswald C; Marshall FH
Trends Pharmacol Sci; 2017 Sep; 38(9):837-847. PubMed ID: 28648526
[TBL] [Abstract][Full Text] [Related]
75. "Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu
Hellyer SD; Albold S; Wang T; Chen ANY; May LT; Leach K; Gregory KJ
Mol Pharmacol; 2018 May; 93(5):504-514. PubMed ID: 29514854
[TBL] [Abstract][Full Text] [Related]
76. Complex pharmacology of novel allosteric free fatty acid 3 receptor ligands.
Hudson BD; Christiansen E; Murdoch H; Jenkins L; Hansen AH; Madsen O; Ulven T; Milligan G
Mol Pharmacol; 2014 Aug; 86(2):200-10. PubMed ID: 24870406
[TBL] [Abstract][Full Text] [Related]
77. Allosteric modulation of kinases and GPCRs: design principles and structural diversity.
Lewis JA; Lebois EP; Lindsley CW
Curr Opin Chem Biol; 2008 Jun; 12(3):269-80. PubMed ID: 18342020
[TBL] [Abstract][Full Text] [Related]
78. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
Grundmann M; Bender E; Schamberger J; Eitner F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
[TBL] [Abstract][Full Text] [Related]
79. The operational model of allosteric modulation of pharmacological agonism.
Jakubík J; Randáková A; Chetverikov N; El-Fakahany EE; Doležal V
Sci Rep; 2020 Sep; 10(1):14421. PubMed ID: 32879329
[TBL] [Abstract][Full Text] [Related]
80. COR758, a negative allosteric modulator of GABA
Porcu A; Mostallino R; Serra V; Melis M; Sogos V; Beggiato S; Ferraro L; Manetti F; Gianibbi B; Bettler B; Corelli F; Mugnaini C; Castelli MP
Neuropharmacology; 2021 May; 189():108537. PubMed ID: 33798546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
